These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964 [TBL] [Abstract][Full Text] [Related]
4. Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors. Ettari R; Nizi E; Di Francesco ME; Dude MA; Pradel G; Vicík R; Schirmeister T; Micale N; Grasso S; Zappalà M J Med Chem; 2008 Feb; 51(4):988-96. PubMed ID: 18232656 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of protein-protein interaction mimics as Plasmodium falciparum cysteine protease, falcipain-2 inhibitors. Rizzi L; Sundararaman S; Cendic K; Vaiana N; Korde R; Sinha D; Mohmmed A; Malhotra P; Romeo S Eur J Med Chem; 2011 Jun; 46(6):2083-90. PubMed ID: 21429631 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of α-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum. Weldon DJ; Shah F; Chittiboyina AG; Sheri A; Chada RR; Gut J; Rosenthal PJ; Shivakumar D; Sherman W; Desai P; Jung JC; Avery MA Bioorg Med Chem Lett; 2014 Mar; 24(5):1274-9. PubMed ID: 24507921 [TBL] [Abstract][Full Text] [Related]
8. Novel peptidomimetics containing a vinyl ester moiety as highly potent and selective falcipain-2 inhibitors. Ettari R; Micale N; Schirmeister T; Gelhaus C; Leippe M; Nizi E; Di Francesco ME; Grasso S; Zappalà M J Med Chem; 2009 Apr; 52(7):2157-60. PubMed ID: 19296600 [TBL] [Abstract][Full Text] [Related]
9. Development of rhodesain inhibitors with a 3-bromoisoxazoline warhead. Ettari R; Tamborini L; Angelo IC; Grasso S; Schirmeister T; Lo Presti L; De Micheli C; Pinto A; Conti P ChemMedChem; 2013 Dec; 8(12):2070-6. PubMed ID: 24243827 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials. Praveen Kumar S; Gut J; Guedes RC; Rosenthal PJ; Santos MM; Moreira R Eur J Med Chem; 2011 Mar; 46(3):927-33. PubMed ID: 21295887 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents. Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors. Ettari R; Micale N; Grazioso G; Bova F; Schirmeister T; Grasso S; Zappalà M ChemMedChem; 2012 Sep; 7(9):1594-600. PubMed ID: 22753258 [TBL] [Abstract][Full Text] [Related]
13. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors. Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894 [TBL] [Abstract][Full Text] [Related]
14. Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins. Nizi E; Sferrazza A; Fabbrini D; Nardi V; Andreini M; Graziani R; Gennari N; Bresciani A; Paonessa G; Harper S Bioorg Med Chem Lett; 2018 May; 28(9):1540-1544. PubMed ID: 29615344 [TBL] [Abstract][Full Text] [Related]
15. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Reich SH; Prins TJ; Marakovits JT; Littlefield ES; Zhou R; Tikhe J; Ford CE; Wallace MB; Meador JW; Ferre RA; Brown EL; Binford SL; Harr JE; DeLisle DM; Worland ST J Med Chem; 1998 Jul; 41(15):2806-18. PubMed ID: 9667970 [TBL] [Abstract][Full Text] [Related]
16. Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids. Breuning A; Degel B; Schulz F; Büchold C; Stempka M; Machon U; Heppner S; Gelhaus C; Leippe M; Leyh M; Kisker C; Rath J; Stich A; Gut J; Rosenthal PJ; Schmuck C; Schirmeister T J Med Chem; 2010 Mar; 53(5):1951-63. PubMed ID: 20131843 [TBL] [Abstract][Full Text] [Related]
17. Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense. Di Chio C; Previti S; Amendola G; Cosconati S; Schirmeister T; Zappalà M; Ettari R ChemMedChem; 2020 Jun; 15(11):995-1001. PubMed ID: 32329206 [TBL] [Abstract][Full Text] [Related]
18. First examples of peptidomimetic inhibitors of interleukin-1 beta converting enzyme. Dolle RE; Prouty CP; Prasad CV; Cook E; Saha A; Ross TM; Salvino JM; Helaszek CT; Ator MA J Med Chem; 1996 Jun; 39(13):2438-40. PubMed ID: 8691439 [No Abstract] [Full Text] [Related]
19. Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2. Sharma RK; Younis Y; Mugumbate G; Njoroge M; Gut J; Rosenthal PJ; Chibale K Eur J Med Chem; 2015 Jan; 90():507-18. PubMed ID: 25486422 [TBL] [Abstract][Full Text] [Related]
20. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Reich SH; Marakovits JT; Prins TJ; Zhou R; Tikhe J; Littlefield ES; Bleckman TM; Wallace MB; Little TL; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; DeLisle DM; Worland ST J Med Chem; 1998 Jul; 41(15):2819-34. PubMed ID: 9667971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]